James P. Moran - Sep 25, 2024 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Role: Director
Signature: /s/ James P Moran
Stock symbol: IGC
Transactions as of: Sep 25, 2024
Transactions value $: $200,000
Form type: 4
Date filed: 9/27/2024, 04:05 PM
Previous filing: Mar 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGC	Common Stock	Purchase	$200K	+588K	+166.09%	$0.34	942K	Sep 25, 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of IGC Pharma, Inc. ("IGC") common stock purchased directly from IGC by Moran Global Strategies, Inc ("MGS"), a Virginia corporation that is owned by James Moran a director of IGC, subject to the terms and conditions set forth in the 2024 Share Purchase Agreement filed with the SEC on Form 8-K on September 25, 2024. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Content

Represents shares of IGC Pharma, Inc. ("IGC") common stock purchased directly from IGC by Moran Global Strategies, Inc ("MGS"), a Virginia corporation that is owned by James Moran a director of IGC, subject to the terms and conditions set forth in the 2024 Share Purchase Agreement filed with the SEC on Form 8-K on September 25, 2024. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.